There was a lot of great information at this year’s ADA Scientific Sessions on the sodium glucose co-transporter 2 (SGLT2) inhibitors both alone and in combination with other medications, and we have a review for you. Canagliflozin Canagliflozin has demonstrated improvement in glycemic control, body weight, and blood pressure across …
Read More »Monthly Archives: June 2014
A1c Goals Lowered for Children with Type 1 Diabetes
A1c Goals Lowered for Children with Type 1 Diabetes See this week’s Item #1.
Read More »Powerhouse Fruits and Vegetables
Powerhouse Fruits and Vegetables What’s a "powerhouse" fruit or vegetable? According to a new study published in a Centers for Disease Control and Protection journal, they’re foods that are "most strongly associated with reduced chronic disease risk." They also contain 17 essential nutrients in quantities that constitute 10 percent or more of …
Read More »FlexTouch® Insulin Analog Pen
FlexTouch® Insulin Analog Pen FlexTouch® is the first and only prefilled insulin delivery device with no push-button extension and is prefilled with long-acting insulin Levemir® (insulin detemir [rDNA origin] injection). It offers several key features: as 1) Prefilled insulin pens containing 3 mL (300 units) of insulin detemir 2) Doses …
Read More »ADA: Walkable Neighborhoods Cut Diabetes Rates
Residents of areas that encourage walking also have lower obesity rates. Those are the finding from two studies that showed those living in an area that encourages walking are also three times more likely to walk or bike and half as likely to drive to get from one place to …
Read More »ADA: CKD Is a Type 2 Diabetes Risk Equivalent in CAD Patients
Among patients with coronary artery disease, those who have both chronic kidney disease and type 2 diabetes face a significantly increased risk of cardiovascular events, compared with those who have either condition separately. The researchers found that the risk of cardiovascular events was significantly higher in patients with type 2 …
Read More »Are the New Guidelines for Lipids Appropriate for People with Diabetes?
The new guidelines divide patients into four groups for whom statin treatment is recommended: individuals with cardiovascular disease; individuals with LDL cholesterol (LDL-C) levels higher than 190 mg/dL; individuals with diabetes, between the ages of 40-75, with LDL-C levels 70-189 mg/dL; and individuals without diabetes or cardiovascular disease, with LDL-C …
Read More »ADA: New HbA1c Target of 7.5% for Type 1 Children and Older Adults
Recent scientific evidence and better tools to monitor for hypoglycemia helped establish the new position statement…. Anne Peters, MD, FACP, professor at the Keck School of Medicine, University of Southern California, said during a press conference at the American Diabetes Association’s 74th Scientific Sessions, “Our goal here is to present …
Read More »ADA: Bionic Pancreas Effective in Reducing Glucose Over Multiple Days
An automated "bionic" pancreas that incorporates glucagon as well as insulin has shown improved blood glucose for five consecutive days in a study of patients with type 1 diabetes….
Read More »ADA: The New Lipid Guidelines, Do They Work for Diabetes?
Some diabetes experts have expressed concerns about recent national guidelines on lipid management, criticizing a lack of LDL cholesterol targets and little direction for management with drugs beyond statins….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.